Well-established, standardized sample collection and stabilization, preparation, and detection solutions, as well as innovative automation platforms, allow effective identification and development of novel drugs. QIAGEN solutions allow you to overcome the challenges of researching, developing, and commercializing safer and more targeted medicines, and companion diagnostics for those medicines, with greater success and efficiency. ...
Read more
Well-established, standardized sample collection and stabilization, preparation, and detection solutions, as well as innovative automation platforms, allow effective identification and development of novel drugs. QIAGEN solutions allow you to overcome the challenges of researching, developing, and commercializing safer and more targeted medicines, and companion diagnostics for those medicines, with greater success and efficiency.
QIAGEN’s sample and assay technologies fit perfectly into the drug discovery workflow, from early drug discovery to safety assessment and preclinical studies. By enabling establishment of standardized techniques, QIAGEN solutions accelerate target identification — the identification of biological targets involved in disease etiology that can be effectively targeted by a therapeutic compound — thereby speeding up the path to discovery. Proven sample collection and purification solutions, along with our portfolio of genomic, transcriptomic, and proteomic technologies, facilitate the identification of biomarkers and their corresponding genes.
QIAGEN also delivers important solutions for target validation — proving that DNA, RNA, or a protein molecule is directly involved in a disease process and is a suitable target for development of a new therapeutic drug. Detailed studies of individual gene targets are required to pinpoint the drug targets that are most amenable to therapeutic intervention. Analysis of gene regulation, knockdown confirmation, and mutation detection, along with analysis of protein structure and function, ensure accurate target validation.
Complete service solutions allow you to streamline your drug discovery and development workflow. The QIAGEN Service Core provides genomic- and expression-based analysis, as well as nucleic acid isolation. We also offer a Companion Diagnostics program and will work with you to co-develop individual companion diagnostics by offering proven global regulatory expertise, a complete in vitro diagnostic menu and operations, and demonstrated experience in companion diagnostic co-development.
Standardization of operating procedures is an important objective as part of good laboratory practice. QIAGEN automated systems are designed and built for ease of use, process standardization, and reliability. All our systems give high performance and fast results without the need for time-consuming optimization. Automated systems that process samples in 96-well format are also available and are preinstalled with optimized protocols for sample preparation, sequencing, genotyping, methylation, and gene expression applications.
Hide details